JASON FOLSOMTREXLER: Open Payments
NPI 1508507872 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,401 in 113 payments from 20 companies in 2025. Trend: 2023 $853 · 2024 $1,394 · 2025 $2,401
Food & beverage: $2,373Education: $27
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 18 | $341 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $288 |
| ABBVIE INC. | 16 | $287 |
| Neurocrine BioSciences, Inc. | 12 | $261 |
| E.R. Squibb & Sons, L.L.C. | 8 | $248 |
| Vanda Pharmaceuticals Inc. | 10 | $200 |
| Axsome Therapeutics, Inc. | 7 | $173 |
| Noven Therapeutics, LLC | 2 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Lundbeck LLC | 4 | $69 |
Products named: Azstarys, CAPLYTA, VRAYLAR, INGREZZA, COBENFY, Auvelity, Xelstrym, HETLIOZ.
Industry payments across FL — which companies pay providers there.
